Technology-driven isotopic labelling in API development
Isotopic labelling of APIs is becoming more challenging, particularly for complex targeted therapies.
The application of biocatalytic tools can introduce complex functionality in a single step and reduce the cost of developing labelled biomolecules and chiral compounds.